Rituximab (Mabthera™, Rituxan™) in Patients with Recurrent Indolent Lymphoma: Evaluation of Safety and Efficacy in a Multicenter Study

Author: Walewski J.   Kraszewska E.   Mioduszewska O.   Romejko-Jarosińska J.   Hellmann A.   Czyz J.   Holowiecki J.   Kopera M.   Grosicki S.   Komarnicki M.   Rumianowski L.   Kuliczkowski K.   Wróbel T.   Dwilewicz-Trojaczek J.   Robak T.   Warzocha K.   Zaluski J.   Wójcik E.   Dmoszyńska A.   Walter-Croneck A.  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.18, Iss.2, 2001-03, pp. : 141-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content